References
- World Health Organisation. 2018. Critical review report: N-ethylnorpentylone. https://www.who.int/medicines/access/controlled-substances/N-Ethylnorpentylone.pdf (Accessed 7th January 2021)
- Costa JL, Cunha KF, Lanaro R, et al. Analytical quantification, intoxication case series, and pharmacological mechanism of action for N-ethylnorpentylone (N-ethylpentylone or ephylone). Drug Test Anal. 2019;11(3):461–471.
- Thirakul P, Hair LS, Bergen KL, et al. Clinical presentation, autopsy results and toxicology findings in an acute n-ethylpentylone fatality. J Anal Toxicol. 2017;41:342–346.
- Ikeji C, Sittambalam CD, Camire LM, et al. Fatal intoxication with N-ethylpentylone: a case report. J Community Hosp Intern Med Perspect. 2018;8(5):307–310.
- Atherton D, Dye D, Robinson CA, et al. n-Ethyl pentylone-related deaths in Alabama. J Forensic Sci. 2019;64(1):304–308.
- Zawadzki M, Nowak K, Szpot P. Fatal intoxication with N-ethylpentylone: a case report and method for determining N-ethylpentylone in biological material. Forensic Toxicol. 2020;38(1):255–263.
- Krotulski AJ, Papsun DM, De Martinis BS, et al. N-Ethyl pentylone (ephylone) intoxications: quantitative confirmation and metabolite identification in authentic human biological specimens. J Anal Toxicol. 2018;42(7):467–475.
- Hill SL, Najafi J, Dunn M, et al. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study. Clin Toxicol (Phila). 2016;54(8):638–643.
- Hill SL, Dunn M, Cano C, et al. Human toxicity caused by indole and indazole carboxylate synthetic cannabinoid receptor agonists: from horizon scanning to notification. Clin Chem. 2018;64(2):346–354.
- Welch Emerging Drugs and Idenytofocaiton of Novel Substances Project (WEDINOS) sample results by keyword search. https://www.wedinos.org/db/samples/.
- https://www2.health.vic.gov.au/alcohol-and-drugs/drug-alerts/green-ups-containing-n-ethylpentylone.
- Vallersnes OM, Persett PS, Øiestad EL, et al. Underestimated impact of novel psychoactive substances: laboratory confirmation of recreational drug toxicity in Oslo, Norway. Clin Toxicol (Phila). 2017;55(7):636–644.
- Abouchedid R, Hudson S, Thurtle N, et al. Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015. Clin Toxicol (Phila). 2017;55(5):338–345.
- Wood DM, Ceronie B, Dargan PI. Healthcare professionals are less confident in managing acute toxicity related to the use of new psychoactive substances (NPS) compared with classical recreational drugs. QJM. 2016;109(8):527–529.
- Noseda R, Schmid Y, Scholz I, Euro-DEN Research Group, et al. MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014–2017. Clin Toxicol (Phila). 2021;59(2):131–137.